Gartner, Magic Quadrant for Custom Software Development Services, By Jaideep Thyagarajan, Ryan McKinney, Nathan Davie, 7 October 2026. Gartner and Magic Quadrant are trademarks of Gartner, Inc. and/or its affiliates.
Gartner does not endorse any company, vendor, product or service depicted in its publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner publications consist of the opinions of Gartner’s business and technology insights organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this publication, including any warranties of merchantability or fitness for a particular purpose. This graphic was published by Gartner, Inc. as part of a larger research document and should be evaluated in the context of the entire document. The Gartner document is available upon request from Hexaware.
News
Hexaware Positioned as a Leader in ISG’s Global 2024 Life Sciences Digital Services Report
June 28, 2024
4 min read
Share on
– ISG positioned Hexaware as a Leader in Clinical Development and Patient Engagement for 2024.
– Hexaware also earned Rising Star status in the Commercial Operations – Digital Evolution quadrant.
– ISG highlights Hexaware’s modular Decentralized Clinical Trials Platform and Clinical Data as a Service.
– An exclusive IQVIA Human Data Science Cloud partnership supports commercial operations work.
Hexaware has been positioned as a Leader in two quadrants of the ISG Provider Lens™ Life Sciences Digital Services – Global 2024 report: Clinical Development and Patient Engagement. The report, published by global technology research and advisory firm ISG, assesses service providers based on their capabilities to support digital transformation across the life sciences value chain.
Hexaware was also identified as a Rising Star in the Commercial Operations – Digital Evolution quadrant, reflecting its momentum and future potential in that domain.
Clinical Development: Modular, AI-Enabled Trial Support
In the Clinical Development quadrant, ISG noted Hexaware’s suite of solutions that includes a modular Decentralized Clinical Trials (DCT) Platform, Clinical Process Automation as a Service, and Clinical Data as a Service. These offerings incorporate AI and GenAI to automate trial workflows and improve operational efficiency.
Key features highlighted include:
DCT Platform modules for precision medicine, vaccine, and CGT studies
Support for eConsent, ePRO, eCOA, and contact centers
AI-based automation for tasks like file standardization and trial data processing
Cognitive Contact Center and integrated AI for accelerated insights
Patient Engagement: Integrated Digital Solutions with IoT Support
In the Patient Engagement quadrant, ISG referenced Hexaware’s use of Salesforce Cloud-integrated accelerators and pre-integrated IoT devices (e.g., Apple Watch, Fitbit, BP monitors) to support real-time health tracking and patient interaction.
Noted capabilities include:
Prebuilt hubs for eConsent, outreach, and engagement
Integration with devices to streamline health data collection and response
Secure data exchange supported by partnerships with MuleSoft, Apigee, Boomi, and Microsoft FHIR APIs
Customization support for EDC and CRM integration using SnapLogic
Commercial Operations: Recognized as a Rising Star
Hexaware was recognized as a Rising Star in the Commercial Operations quadrant. ISG cited Hexaware’s:
Exclusive systems integrator partnership with IQVIA’s Human Data Science Cloud (HDSC)
Validated Salesforce-based cell and gene platform for manufacturing support
Field force solutions and omnichannel engagement platforms including PSP Blue and other accelerators for patient and HCP engagement
A Global Partner for Digital Transformation in Life Sciences
Hexaware’s inclusion in multiple quadrants reflects its end-to-end capabilities in transforming the life sciences industry with automation, analytics, cloud-native platforms, and integrated patient and HCP engagement solutions.
Hexaware Named a Leader in Clinical Development in the ISG Provider Lens™ Life Sciences Digital Services 2024 Global Quadrant Study
“Hexaware transforms clinical operations with advanced solutions, driving efficiency and improving patient care.”
— Rohan Sinha, Lead Author, Life Sciences Digital Services Study
Hexaware Named a Leader in Patient Engagement in the ISG Provider Lens™ Life Sciences Digital Services 2024 Global Quadrant Study
“Hexaware redefines patient engagement by seamlessly integrating tailored accelerators and advanced data solutions.”
— Rohan Sinha, Lead Author, Life Sciences Digital Services Study
Hexaware Named a Rising Star in Commercial Operations – Digital Evolution in the ISG Provider Lens™ Life Sciences Digital Services 2024 Global Quadrant Study
“In the dynamic landscape of pharma commercial operations, Hexaware is a beacon of innovation, driving transformative solutions with precision and expertise”
— Sneha Jayanth, Co-Author and Research Analyst, Life Sciences Digital Services Study
